A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer ActivityHui Jing, Hening Lin, Teresa Southard et al.|Cancer Cell|2016Cited by 231
A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer ActivityHui Jing, Hening Lin, Jing Hu et al.|Cancer Cell|2016Cited by 195
Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancerYashira L. Negrón Abril, Robert S. Weiss, Irma Fernández et al.|Oncogene|2021Cited by 87
A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer ActivityHui Jing, Hening Lin, Jing Hu et al.|Cancer Cell|2016Cited by 23